Operated by Ieldas Inc. · Independent methodology · Affiliate-supported. Read our ownership & funding disclosure and how every figure is verified.
GLP1ProviderFinderUS price records
HomeCompare › Care Bare Rx vs PlexusDx

Head-to-head · computed 2026-08-11

Care Bare Rx vs PlexusDx

Care Bare Rx: Care Bare Rx is a cash-pay compounded GLP-1 telehealth service offering both semaglutide and tirzepatide from $199/mo. It operates a lighter clinical model — confirm prescriber availability and refill cadence before enrolling. PlexusDx: PlexusDx sells flat-rate compounded protocols with no membership: $149/month semaglutide injection (flat from 0.25 to 2.0 mg weekly), $249/month tirzepatide injection (flat from 2.5 to 15 mg), a $129/month microdose protocol, and an optional genetic test the company positions as personalization.

Tirzepatide

Care Bare RxPlexusDx
All-in maintenance$199/mo$249/mo
Best plan rate$199/mo$249/mo
12-month total$2,388$2,988
StatusReported · 2026-07-14Provider-stated · 2026-08-11

The arithmetic

On the figures our desk holds, Care Bare Rx's $199 a month undercuts PlexusDx's $249 by $50 a month at the 10 mg/wk maintenance basis — $600 across a year. Care Bare Rx's figure is reported (captured 2026-07-14) and PlexusDx's is provider-stated (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.

Care Bare Rx's tirzepatide ladder runs $199 a month billed monthly. PlexusDx's runs $249 a month billed monthly. On the twelve-month basis Care Bare Rx's $2,388 beats PlexusDx's $2,988 by $600 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.

Semaglutide

Care Bare RxPlexusDx
All-in maintenance$199/mo$149/mo
Best plan rate$199/mo$149/mo
12-month total$2,388$1,788
StatusReported · 2026-07-14Provider-stated · 2026-08-11

The arithmetic

On the figures our desk holds, PlexusDx's $149 a month undercuts Care Bare Rx's $199 by $50 a month at the 2.4 mg/wk maintenance basis — $600 across a year. PlexusDx's figure is provider-stated (captured 2026-08-11) and Care Bare Rx's is reported (captured 2026-07-14); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.

Care Bare Rx's semaglutide ladder runs $199 a month billed monthly. PlexusDx's runs $149 a month billed monthly. On the twelve-month basis PlexusDx's $1,788 beats Care Bare Rx's $2,388 by $600 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.

Where the structures genuinely differ

On verifiability, Care Bare Rx names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while PlexusDx's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice.

Structure, side by side

Care Bare Rx

  • MembershipNone
  • Dose policyFlat (from $199, no per-dose increases specified publicly)
  • CommitmentMonthly (confirm at enrollment)
  • CancellationPer provider terms
  • PharmacyPartner 503A pharmacy (not named publicly)

PlexusDx

  • MembershipNone
  • Dose policyDose-flat per published protocol pricing (semaglutide flat across five dose levels; tirzepatide flat across six)
  • CommitmentMonth-to-month
  • CancellationPer published terms; confirm at checkout
  • PharmacyLicensed 503A compounders (per company; names undisclosed on captured materials)

What our desk is watching on each

Care Bare Rx: Lighter clinical model; confirm prescriber availability, refill cadence and pharmacy identity before enrolling. Reported status from RangeYourself 2026 data.

PlexusDx: Provider-stated throughout: every figure here comes from PlexusDx's own published materials, which the company distributes inside competitor 'reviews' on its blog — a marketing format worth noting even when the numbers are consistent. The optional 'Precision Peptide Genetic Test' is an upsell whose clinical utility for dose selection is not established by the class's trial record; the microdose protocol is sub-maintenance by design and is not ranked at the maintenance basis. Pharmacy names undisclosed on captured materials — the verification workflow stalls at step one until answered. Independent checkout capture pending.

Questions people ask

Is Care Bare Rx or PlexusDx cheaper in 2026?

The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.

What does Care Bare Rx vs PlexusDx miss that checkout will show?

Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.

Why do you compare at the maintenance dose instead of the starting dose?

Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.

What do Care Bare Rx and PlexusDx cost over a full year of tirzepatide?

On the plans our database holds, a year of tirzepatide runs $2,388 at Care Bare Rx and $2,988 at PlexusDx — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.

Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Care Bare Rx · PlexusDx. Official sites: Care Bare Rx ↗ · PlexusDx ↗. Nothing here is medical advice.